Q2 2026 Holdings
Filed 2026-08-14 | 277 holdings | $2.2B | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Abivax SA(ABVX) | SPONSORED ADS | 00370M103 | $240.5M | 1,804,703 | 11.0% |
| Protagonist Therapeutics Inc(PTGX) | COM | 74366E102 | $117.8M | 960,863 | 5.4% |
| Roivant Sciences LTD(ROIV) | SHS | G76279101 | $111.7M | 3,157,008 | 5.1% |
| State STR Spdr S&P 500 ETF T(SPY) | TR UNIT | 78462F103 | $96.4M | 129,087 | 4.4% |
| Immunovant Inc(IMVT) | COM | 45258J102 | $89.8M | 2,330,716 | 4.1% |
| ZAI LAB LTD(ZLAB) | ADR | 98887Q104 | $64.0M | 3,369,034 | 2.9% |
| Agios Pharmaceuticals Inc(AGIO) | COM | 00847X104 | $47.8M | 1,288,053 | 2.2% |
| Crinetics Pharmaceuticals in(CRNX) | COM | 22663K107 | $45.7M | 1,222,080 | 2.1% |
| EA Series Trust(BOXX) | ALPHA ARCH 1-3 | 02072L565 | $39.5M | 337,125 | 1.8% |
| Cytokinetics Inc(CYTK) | COM NEW | 23282W605 | $39.0M | 457,907 | 1.8% |
| Septerna Inc(SEPN) | COM | 81734D104 | $31.5M | 940,747 | 1.4% |
| Anteris Technologies Global(AVR) | COM | 03675P102 | $31.0M | 3,145,096 | 1.4% |
| Editas Medicine Inc(EDIT) | COM | 28106W103 | $28.8M | 8,889,000 | 1.3% |
| Denali Therapeutics Inc(DNLI) | COM | 24823R105 | $26.5M | 1,029,080 | 1.2% |
| Spyre Therapeutics Inc(SYRE) | COM NEW | 00773J202 | $25.2M | 283,982 | 1.2% |
| VIR Biotechnology Inc(VIR) | COM | 92764N102 | $25.0M | 2,456,677 | 1.1% |
| Praxis Precision Medicines I(PRAX) | COM NEW | 74006W207 | $24.9M | 74,253 | 1.1% |
| Insmed Inc(INSM) | COM PAR $.01 | 457669307 | $24.4M | 228,520 | 1.1% |
| Celldex Therapeutics Inc New(CLDX) | COM NEW | 15117B202 | $23.1M | 619,542 | 1.1% |
| Viking Therapeutics Inc(VKTX) | COM | 92686J106 | $22.4M | 574,038 | 1.0% |
| Taysha Gene Therapies Inc(TSHA) | COM SHS | 877619106 | $20.7M | 3,040,466 | 0.9% |
| Monopar Therapeutics Inc(MNPR) | COM NEW | 61023L207 | $20.1M | 217,595 | 0.9% |
| Ovid Therapeutics Inc(OVID) | COM | 690469101 | $20.0M | 7,417,479 | 0.9% |
| Enliven Therapeutics Inc(ELVN) | COM | 29337E102 | $19.7M | 387,718 | 0.9% |
| Enanta Pharmaceuticals Inc(ENTA) | COM | 29251M106 | $19.6M | 1,344,510 | 0.9% |
| Ishares TR(IWM)Put | RUSSELL 2000 ETF | 464287655 | $18.8M | 62,500 | 0.9% |
| State STR Spdr S&P 500 ETF T(SPY)Put | TR UNIT | 78462F103 | $18.7M | 25,000 | 0.9% |
| Nektar Therapeutics(NKTR) | COM NEW | 640268306 | $17.0M | 244,184 | 0.8% |
| Inspire MED SYS Inc(INSP) | COM | 457730109 | $16.7M | 374,617 | 0.8% |
| Revolution Medicines Inc(RVMD) | COM | 76155X100 | $16.4M | 87,509 | 0.8% |
| Establishment Labs Hldgs Inc(ESTA) | COM | G31249108 | $15.9M | 185,619 | 0.7% |
| Prothena Corp PLC(PRTA) | SHS | G72800108 | $15.2M | 1,554,535 | 0.7% |
| Rhythm Pharmaceuticals Inc(RYTM) | COM | 76243J105 | $15.1M | 136,158 | 0.7% |
| Inhibikase Therapeutics Inc(IKT) | COM NEW | 45719W205 | $15.0M | 7,387,205 | 0.7% |
| Uniqure NV(QURE) | SHS | N90064101 | $15.0M | 324,672 | 0.7% |
| Rallybio Corp(RLYB) | COM | 75120L209 | $14.8M | 926,352 | 0.7% |
| Regeneron Pharmaceuticals(REGN) | COM | 75886F107 | $13.8M | 22,208 | 0.6% |
| Inventiva SA(IVA) | ADS | 46124U107 | $13.6M | 3,606,656 | 0.6% |
| Sutro Biopharma Inc(STRO) | COM SHS | 869367201 | $13.4M | 404,014 | 0.6% |
| Ionis Pharmaceuticals Inc(IONS) | COM | 462222100 | $13.2M | 166,286 | 0.6% |
| Bridgebio Pharma Inc(BBIO) | COM | 10806X102 | $13.2M | 176,689 | 0.6% |
| Sarepta Therapeutics Inc(SRPT) | COM | 803607100 | $13.1M | 730,649 | 0.6% |
| Cytomx Therapeutics Inc.(CTMX) | COM | 23284F105 | $12.6M | 3,365,118 | 0.6% |
| VOR Biopharma Inc(VOR) | COM NEW | 929033207 | $12.5M | 680,626 | 0.6% |
| Spdr Series Trust(BIL) | ST STR BLO 1 ETF | 78468R663 | $12.4M | 135,585 | 0.6% |
| Equillium Inc(EQ) | COM | 29446K106 | $12.0M | 3,758,569 | 0.6% |
| Adlai Nortye LTD(ANL) | SPONSORED ADS | 00704R109 | $11.7M | 1,017,805 | 0.5% |
| Climb BIO Inc(CLYM) | COM | 28658R106 | $10.7M | 822,649 | 0.5% |
| Spdr Series Trust(XBI)Put | ST STR SP BIOT | 78464A870 | $10.7M | 67,400 | 0.5% |
| Helix Acquisition Corp III | USD CL A ORD SHS | G4444S107 | $10.6M | 1,000,000 | 0.5% |